The European Generics Outlook: A country-by-country analysis of developing market opportunities and revenue defense strategies

Executive Summary

The European generic marketplace is perplexing and complicated, full of contradictions and inconsistencies - manufacturers of generic drugs are presented with unprecedented opportunities as large numbers of brand name products lose their patent protection. This is placing greater pressures than ever on multinationals to search for ways to extend their products’ patents and defend their market share. This management report from Reuters Business Insight critically analyzes the changing market conditions and the impact of these opportunities on the generics industry and multinational R&D companies. ’The European Generics Outlook: A country-by-country analysis of developing market opportunities and revenue defense strategies’, assesses the drivers and inhibitors of generics market growth within 15 European markets. The report provides detailed insights into European market dynamics, and explores strategies for survival for generic companies and defense strategies for multinationals’ branded drugs. This report will enable you to perfect your generics strategy and yield the greatest return from your investment.